SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-002214
Filing Date
2024-01-04
Accepted
2024-01-04 19:19:09
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3868
  Complete submission text file 0000950170-24-002214.txt   5345
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O WEREWOLF THERAPEUTICS, INC. 200 TALCOTT AVE., 2ND FLOOR WATERTOWN MA 02472
Business Address
Atkins Michael B. (Reporting) CIK: 0002004793 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 24513992